StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.84−0.03 (-1.05%)

Close on Nov 17, 2026Market cap $560.13MP/E –Yield –

Wave Life Sciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Wave Life Sciences

Wave Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Wave Life Sciences figures

See a number that looks wrong?